QAdvis is delighted to announce that Anna-Karin Alm has joined QAdvis as the new CEO, effective from February 1st 2025.

We are delighted to announce the appointment of Anna-Karin Alm as the new CEO of QAdvis AB, succeeding Robert Ginsberg, who has decided to step down from this position. Anna-Karin also assumes the QA/RA Business Area Head position in Aurevia, and is a member of the Aurevia Management team.

Anna-Karin is an experienced leader with over 20 years in leading roles within the Medical Technology sector. She is dedicated to defining and improving organizations and has worked in medical device companies throughout her career.

Anna-Karin brings a diverse set of leadership skills, having held positions such as CEO, Director of Medical Device Compliance, Director of Operational Excellence, Senior Consultant and Business Development Manager. Anna-Karin has also led multiple cross-functional and cross-cultural development teams and improvement projects. She emphasizes that product quality and corporate quality are essential for medtech companies, and she is committed to securing the success of our company by streamlining these services. Most recently, she has worked at Prevas AB (SDS MedteQ AB) and SHL Group AB.

 “I am delighted to introduce Anna-Karin as our new CEO. She brings a wealth of experience, fresh perspectives, and a strong commitment to the values that have shaped our company. I have full confidence that she will lead QAdvis into an exciting future together with Aurevia” says former QAdvis CEO Robert Ginsberg.

“I feel proud to be part of this experienced and skilled team of quality and regulatory experts within QAdvis and Aurevia. Our team has a broad set of skills, not only within our own business area, but also with colleagues within the CRO part of the organization. Together we will enable access for clients to the best experts within the broad medtech field.”, concludes Anna-Karin Alm.

Anna-Karins special interest in making the whole organization grow through strategic deployment work will be a great asset to QAdvis continued growth together with Aurevia.